46K Stock Overview Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteIRADIMED CORPORATION Competitors Price History & Performance
Summary of share price highs, lows and changes for IRADIMED Historical stock prices Current Share Price US$51.50 52 Week High US$53.50 52 Week Low US$37.40 Beta 0.83 1 Month Change 4.67% 3 Month Change 17.05% 1 Year Change 23.80% 3 Year Change 31.38% 5 Year Change 146.00% Change since IPO 179.62%
Recent News & Updates
Investor sentiment improves as stock rises 19% Nov 12
Upcoming dividend of US$0.15 per share Nov 08
Third quarter 2024 earnings released: EPS: US$0.40 (vs US$0.40 in 3Q 2023) Nov 01 Iradimed Corporation Revises Earnings Guidance for the Year 2024
IRADIMED CORPORATION to Report Q3, 2024 Results on Oct 31, 2024 Oct 25
Upcoming dividend of US$0.15 per share Aug 13 See more updates
Investor sentiment improves as stock rises 19% Nov 12
Upcoming dividend of US$0.15 per share Nov 08
Third quarter 2024 earnings released: EPS: US$0.40 (vs US$0.40 in 3Q 2023) Nov 01 Iradimed Corporation Revises Earnings Guidance for the Year 2024
IRADIMED CORPORATION to Report Q3, 2024 Results on Oct 31, 2024 Oct 25
Upcoming dividend of US$0.15 per share Aug 13
Second quarter 2024 earnings released: EPS: US$0.39 (vs US$0.33 in 2Q 2023) Aug 02 IRADIMED CORPORATION Declares A Regular Quarterly Cash Dividend, Payable on August 30, 2024
IRADIMED CORPORATION to Report Q2, 2024 Results on Aug 01, 2024 Jul 25
Independent Director recently sold €78k worth of stock Jun 06 IRADIMED CORPORATION Declares Regular Quarterly Cash Dividend, Payable on May 30, 2024
IRADIMED CORPORATION, Annual General Meeting, Jun 20, 2024 May 01
IRADIMED CORPORATION to Report Q1, 2024 Results on May 02, 2024 Apr 28
Full year 2023 earnings released: EPS: US$1.36 (vs US$1.02 in FY 2022) Mar 04
Full year 2023 earnings released: EPS: US$1.36 (vs US$1.02 in FY 2022) Feb 09
IRadimed Corporation Provides Revenue Guidance for the First Quarter and Full Year of 2024 Feb 08
IRadimed Corporation to Report Q4, 2023 Results on Feb 08, 2024 Feb 02 IRadimed Corporation Approves Initiation of Regular Quarterly Dividend, Payable on January 12, 2024
Independent Director recently sold €114k worth of stock Nov 14
Third quarter 2023 earnings released: EPS: US$0.40 (vs US$0.27 in 3Q 2022) Nov 05
Iradimed Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year 2023 Nov 04
IRadimed Corporation to Report Q3, 2023 Results on Nov 03, 2023 Oct 27
IRadimed Corporation Provides Earnings Guidance for the Third Quarter and for the Full Year of 2023 Aug 04
Second quarter 2023 earnings released: EPS: US$0.33 (vs US$0.26 in 2Q 2022) Aug 04
IRadimed Corporation to Report Q2, 2023 Results on Aug 03, 2023 Jul 29
Independent Director recently sold €117k worth of stock May 11 IRadimed Corporation Revises Earnings Guidance for the Year 2023
First quarter 2023 earnings released: EPS: US$0.27 (vs US$0.20 in 1Q 2022) May 05
Investor sentiment deteriorates as stock falls 15% Feb 11
Full year 2022 earnings released: EPS: US$1.02 (vs US$0.76 in FY 2021) Feb 05
Iradimed Corporation Approves Special Cash Dividend, Payable on February 21, 2023 Feb 03
IRadimed Corporation to Report Q4, 2022 Results on Feb 02, 2023 Jan 27
Investor sentiment improves as stock rises 16% Jan 25
IRadimed Corporation Provides Earnings Guidance for the First Quarter of 2023 and Full Year 2023 Jan 20
Third quarter 2022 earnings released: EPS: US$0.27 (vs US$0.21 in 3Q 2021) Nov 04
Iradimed Corporation Provides Revenue Guidance for the Fourth Quarter and Full Year 2022 Nov 04
IRadimed Corporation to Report Q3, 2022 Results on Nov 03, 2022 Oct 28
IRadimed Corporation Provides Revenue Guidance for the Third Quarter Ended September 30, 2022 Oct 12
IRadimed Corporation Announces Board Changes Oct 07
Independent Director recently sold €113k worth of stock Aug 06
Insufficient new directors Aug 01
Second quarter 2022 earnings released: EPS: US$0.26 (vs US$0.12 in 2Q 2021) Jul 30 Iradimed Corporation Revises Earnings Guidance for the Full Year 2022
IRadimed Corporation to Report Q2, 2022 Results on Jul 29, 2022 Jul 23
Insufficient new directors Jul 02
IRadimed Corporation Names John F. Glenn as Chief Financial Officer, Effective on or before June 20, 2022 May 27
Investor sentiment deteriorated over the past week May 06
First quarter 2022 earnings released: EPS: US$0.20 (vs US$0.11 in 1Q 2021) May 02 Iradimed Corporation Revises Earnings Guidance for the Full Year 2022
IRadimed Corporation to Report Q1, 2022 Results on Apr 29, 2022 Apr 06
COO, CFO & Secretary recently sold €846k worth of stock Feb 13
Investor sentiment improved over the past week Feb 11
IRadimed Corporation Announces Special Share Cash Dividend, Payable on February 24, 2022 Feb 08
iRadimed Corporation Provides Earnings Guidance for the First Quarter and Full Year of 2022 Feb 05
Independent Director recently sold €785k worth of stock Dec 14
Independent Director recently sold €119k worth of stock Nov 06
Third quarter 2021 earnings released: EPS US$0.21 (vs US$0.088 in 3Q 2020) Oct 30
Second quarter 2021 earnings released: EPS US$0.12 (vs US$0.17 loss in 2Q 2020) Jul 31
First quarter 2021 earnings released: EPS US$0.11 (vs US$0.15 in 1Q 2020) May 04
IRadimed Corporation Provides Financial Guidance for Fiscal Year 2021 May 01
Full year 2020 earnings released: EPS US$0.11 (vs US$0.85 in FY 2019) Feb 06
Revenue beats expectations Feb 06
New 90-day high: €21.40 Feb 04
IRadimed Corporation to Report Q4, 2020 Results on Feb 04, 2021 Jan 28
Third quarter 2020 earnings released: EPS US$0.088 Nov 08
Revenue beats expectations Nov 08
New 90-day high: €19.40 Nov 03
Third quarter earnings released Oct 30
Third-quarter earnings released: Revenue beats expectations Oct 30
IRadimed Corporation to Report Q3, 2020 Results on Oct 30, 2020 Oct 10
IRadimed Corporation Withdraws Full-Year 2020 Financial Guidance and Not Providing Any Additional Financial Guidance Aug 01
IRadimed Corporation to Report Q2, 2020 Results on Jul 30, 2020 Jul 18
IRadimed Corporation(NasdaqCM:IRMD) dropped from Russell 2000 Dynamic Index Jul 05 Shareholder Returns 46K DE Medical Equipment DE Market 7D 2.0% -0.5% -0.3% 1Y 23.8% -8.4% 7.0%
See full shareholder returns
Return vs Market: 46K exceeded the German Market which returned 7% over the past year.
Price Volatility Is 46K's price volatile compared to industry and market? 46K volatility 46K Average Weekly Movement 6.1% Medical Equipment Industry Average Movement 6.6% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.6% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 46K has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 46K's weekly volatility (6%) has been stable over the past year.
About the Company IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories.
Show more IRADIMED CORPORATION Fundamentals Summary How do IRADIMED's earnings and revenue compare to its market cap? 46K fundamental statistics Market cap €660.10m Earnings (TTM ) €17.90m Revenue (TTM ) €68.51m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 46K income statement (TTM ) Revenue US$71.31m Cost of Revenue US$16.30m Gross Profit US$55.00m Other Expenses US$36.38m Earnings US$18.63m
Dividends
2.0% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/26 01:24 End of Day Share Price 2024/12/23 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources IRADIMED CORPORATION is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Lawrence Solow CJS Securities, Inc. Frank Takkinen Lake Street Capital Markets, LLC Scott Henry Roth MKM
Show 1 more analysts